NADAC acquisition cost data for ADZENYS XR-ODT 9.4 MG TABLET. This is a brand-name medication — generic alternatives may be available at lower prices.
| Generic Name | Amphetamine |
| Brand Name | Adzenys XR-ODT |
| Manufacturer | Neos Therapeutics Brands, LLC |
| Dosage Form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Pharmacologic Class | Central Nervous System Stimulant |
| Product Type | HUMAN PRESCRIPTION DRUG |
| DEA Schedule | CII |
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 70165001530 | $14.58 | 2022-10-01 | Rx |
| 70165001530 | $14.58 | 2022-10-01 | Rx |
| 70165001530 | $14.58 | 2022-10-01 | Rx |
| 70165001530 | $14.58 | 2022-10-01 | Rx |
| 70165001530 | $14.58 | 2022-10-01 | Rx |
| 70165001530 | $14.58 | 2022-10-01 | Rx |
| 70165001530 | $14.58 | 2022-10-01 | Rx |
| 70165001530 | $14.58 | 2022-10-01 | Rx |
| 70165001530 | $14.58 | 2022-10-01 | Rx |
| 70165001530 | $14.58 | 2022-10-01 | Rx |
Generic: Amphetamine | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $441.1K | 1,068 | 191 | $11.66 |
| 2020 | $490.5K | 1,073 | 183 | $12.92 |
| 2021 | $545.7K | 1,041 | 188 | $14.94 |
| 2022 | $576.3K | 1,041 | 205 | $15.43 |
| 2023 | $1.2M | 1,972 | 466 | $16.70 |
These generic drugs may be equivalent alternatives at lower prices.
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.